Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessio Aghemo

Showing results (1-10 of 318) with videos related to

Pageof 32
Sort By:
Digestive Diseases and Sciences|June 28, 2012
Understanding the role of PNPLA3 genetic variants in patients with chronic hepatitis C infectionAlessio Aghemo
Gastroenterology & Hepatology|September 1, 2018
Update on HCC Management and Review of the New EASL GuidelinesAlessio Aghemo
Gastroenterology|March 24, 2012
Interferon-free oral therapy for hepatitis C: "faraway, so close!"Alessio Aghemo, Massimo Colombo
Minerva Gastroenterologica E Dietologica|October 9, 2015
Directly acting antivirals against hepatitis C virus: mechanisms of action and impact of resistant associated variantsCaterina Premoli, Alessio Aghemo
Gastroenterology|March 3, 2009
Cirrhosis regression in chronic hepatitis C: an old tale with a new endingAlessio Aghemo, Massimo Colombo
Gastroenterology|May 4, 2010
Genetic variation in interleukin-28B predicts hepatitis C treatment-induced viral clearance in genotype 1 patients: the dawn of a new era?Alessio Aghemo, Massimo Colombo
Gastroenterology|October 6, 2016
Hepatitis C Therapy: Game Over!Alessio Aghemo, Maria Buti
Journal of Hepatology|August 23, 2015
Hepatitis C virus post-exposure prophylaxis: A reasonable option in the era of pangenotypic direct-acting antivirals?Raffaele Bruno, Alessio Aghemo
Gastroenterology|January 28, 2009
Cirrhosis regression in chronic hepatitis C: an old tale with a new endingAlessio Aghemo, Massimo Colombo
Gastroenterology|February 7, 2018
Glecaprevir/Pibrentasvir: The Final Piece in the Hepatitis C Virus Treatment Puzzle?Alessio Aghemo, Massimo Colombo
Pageof 32

Showing results (1-10 of 318) with videos related to

Sort By:
Pageof 32
Digestive Diseases and Sciences|June 28, 2012
Understanding the role of PNPLA3 genetic variants in patients with chronic hepatitis C infectionAlessio Aghemo
Gastroenterology & Hepatology|September 1, 2018
Update on HCC Management and Review of the New EASL GuidelinesAlessio Aghemo
Gastroenterology|March 24, 2012
Interferon-free oral therapy for hepatitis C: "faraway, so close!"Alessio Aghemo, Massimo Colombo
Minerva Gastroenterologica E Dietologica|October 9, 2015
Directly acting antivirals against hepatitis C virus: mechanisms of action and impact of resistant associated variantsCaterina Premoli, Alessio Aghemo
Gastroenterology|March 3, 2009
Cirrhosis regression in chronic hepatitis C: an old tale with a new endingAlessio Aghemo, Massimo Colombo
Gastroenterology|May 4, 2010
Genetic variation in interleukin-28B predicts hepatitis C treatment-induced viral clearance in genotype 1 patients: the dawn of a new era?Alessio Aghemo, Massimo Colombo
Gastroenterology|October 6, 2016
Hepatitis C Therapy: Game Over!Alessio Aghemo, Maria Buti
Journal of Hepatology|August 23, 2015
Hepatitis C virus post-exposure prophylaxis: A reasonable option in the era of pangenotypic direct-acting antivirals?Raffaele Bruno, Alessio Aghemo
Gastroenterology|January 28, 2009
Cirrhosis regression in chronic hepatitis C: an old tale with a new endingAlessio Aghemo, Massimo Colombo
Gastroenterology|February 7, 2018
Glecaprevir/Pibrentasvir: The Final Piece in the Hepatitis C Virus Treatment Puzzle?Alessio Aghemo, Massimo Colombo
Pageof 32